Revenue growth remains inconsistent with a 3.4% year-over-year increase in 2026Q1, while operating margins remain deeply negative at -18.2% for the same period.
| Sales/Revenue | 2.9M | 2.88M | 2.99M | 3.8M | 4.04M | 4.63M | 5.21M | 5.55M | 150.09K | 4.22M | 591.44K |
| Revenue Growth % | 0.15% | -3.75% | -21.43% | -5.78% | -12.83% | -11.14% | -6.04% | 3596.55% | -96.44% | 613.13% | - |
| Cost of Goods Sold | 1.75M | 1.96M | 2.24M | 2.54M | 2.62M | 2.78M | 3.52M | 4.38M | 2.91M | 2.69M | 384.42K |
| COGS % of Revenue | - | 68.04% | 75.05% | 66.65% | 64.99% | 60.06% | 67.43% | 78.98% | 1941.73% | 63.81% | 65% |
| Gross Profit | 1.16M | 919.71K | 745.99K | 1.27M | 1.41M | 1.85M | 1.7M | 1.17M | -2.76M | 1.53M | 207.01K |
| Gross Margin % | 39.86% | 31.96% | 24.95% | 33.35% | 35.01% | 39.94% | 32.57% | 21.02% | -1841.73% | 36.19% | 35% |
| Gross Profit Growth % | - | 23.29% | -41.22% | -10.23% | -23.59% | 8.96% | 45.61% | 142.18% | -281.11% | 637.29% | - |
| Operating Expenses | 1.62M | 1.88M | 2.01M | 2.72M | 3.54M | 5.66M | 7.74M | 13.06M | 3.5M | 9.22M | 5.12M |
| OpEx % of Revenue | - | 65.28% | 67.08% | 71.48% | 87.59% | 122.28% | 148.53% | 235.46% | 2333.52% | 218.63% | 865.47% |
| Selling, General & Admin | 880.98K | 853.34K | 756.12K | 2.72M | 3.54M | 5.66M | 7.74M | 13.06M | 3.5M | 9.22M | 5.12M |
| SG&A % of Revenue | - | 29.65% | 25.29% | 71.48% | 87.59% | 122.28% | 148.53% | 235.46% | 2333.52% | 218.63% | 865.47% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.12M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | 189.4% |
| Other Operating Expenses | 736.83K | 1.03M | 1.25M | 0 | 0 | 0 | 0 | 0 | 231.04K | -16.86K | -3.35K |
| Operating Income | -760.54K | -958.72K | -1.26M | -1.45M | -2.12M | -3.81M | -6.05M | -11.9M | -3.58M | -11.27M | -4.91M |
| Operating Margin % | -26.21% | -33.32% | -42.13% | -38.13% | -52.58% | -82.34% | -115.96% | -214.44% | -2387.45% | -267.29% | -830.47% |
| Operating Income Growth % | - | 23.88% | 13.18% | 31.68% | 44.33% | 36.9% | 49.19% | -232.03% | 68.22% | -129.53% | - |
| EBITDA | 1.17M | -958.32K | 0 | -3.97M | -1.84M | -3.74M | -5.81M | -11.86M | -3.54M | -11.2M | -4.51M |
| EBITDA Margin % | 40.33% | -33.3% | - | -104.46% | -45.67% | -80.7% | -111.46% | -213.7% | -2360.24% | -265.49% | -763.27% |
| EBITDA Growth % | 198.56% | - | 100% | -115.52% | 50.67% | 35.67% | 50.99% | -234.69% | 68.36% | -148.05% | - |
| D&A (Non-Cash Add-back) | 2.43M | 404 | 1.26M | 0 | 0 | 76.16K | 234.26K | 41.23K | 40.83K | 76.18K | 397.44K |
| EBIT | -1.12M | -1.46M | -1.03M | -3.97M | -1.84M | -3.81M | -6.05M | -11.29M | -3.53M | -3.17M | -4.92M |
| Net Interest Income | -2.84M | -2.99M | -104.2K | -6.45K | -3.15K | 0 | 0 | 14.05K | -258.8K | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.77K | 0 | 0 | 0 |
| Interest Expense | 2.81M | 2.99M | 104.2K | 6.45K | 3.15K | 0 | 0 | 23.72K | 258.8K | 0 | 0 |
| Other Income/Expense | -3.38M | -3.49M | 123.2K | -2.53M | 276.04K | 0 | -1.36M | 584.99K | -204.2K | -2.87M | -3.35K |
| Pretax Income | -4.14M | -4.44M | -1.14M | -3.98M | -1.85M | -3.81M | -7.4M | -11.31M | -3.79M | -11.29M | -4.92M |
| Pretax Margin % | -142.7% | -154.44% | -38.01% | -104.63% | -45.75% | -82.34% | -141.99% | -203.9% | -2523.5% | -267.69% | -831.03% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 688.11K | -755.65K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -6.09% | 15.37% |
| Net Income | -4.14M | -4.44M | -1.14M | -3.98M | -1.85M | -3.81M | -7.4M | -11.48M | -14.59M | -11.98M | -4.16M |
| Net Margin % | -142.7% | -154.44% | -38.01% | -104.63% | -45.75% | -82.34% | -141.99% | -206.91% | -9722.4% | -284.01% | -703.27% |
| Net Income Growth % | -188.84% | -291.13% | 71.46% | -115.5% | 51.57% | 48.47% | 35.52% | 21.33% | -21.82% | -187.99% | - |
| Net Income (Continuing) | -4.14M | -4.44M | -1.14M | -3.98M | -1.85M | -3.81M | -7.4M | -11.31M | -3.79M | -3.17M | -4.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.90 | -9.15 | -11.70 | -57.90 | -29.55 | -81.60 | -183.90 | -412.35 | -4035.00 | -4794.90 | -1838.40 |
| EPS Growth % | 26.59% | 21.79% | 79.79% | -95.94% | 63.79% | 55.63% | 55.4% | 89.78% | 15.85% | -160.82% | - |
| EPS (Basic) | - | -9.15 | -11.70 | -57.90 | -29.55 | -81.60 | -183.90 | -412.35 | -4035.00 | -4794.90 | -1838.40 |
| Diluted Shares Outstanding | 1.06M | 485.02K | 97.25K | 68.84K | 53.19K | 46.7K | 40.25K | 27.84K | 3.62K | 2.5K | 1.29K |
| Basic Shares Outstanding | 1.06M | 485.02K | 97.25K | 68.84K | 53.19K | 46.7K | 40.25K | 27.84K | 3.62K | 2.5K | 1.29K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |
Liquidity and operational viability
As indicated by the quarterly financial data, SCWorx has struggled to maintain a consistent growth trajectory, with revenue fluctuating between $675.7K and $910.3K over the last ten quarters, ultimately failing to establish a clear path toward sustainable top-line expansion in its core healthcare services.
The revenue volatility suggests that the company's reliance on non-core, transactional business lines creates significant lumpiness in quarterly reporting. Investors should monitor whether the recent 3.4% growth in 2026Q1 represents a genuine turnaround or merely a temporary fluctuation in a broader trend of stagnation.
Based on reported income statements, the company's gross margin has oscillated significantly, reaching a low of 17.5% in 2024Q3 before recovering to 50.2% in 2026Q1, reflecting the inherent instability of a business model that mixes high-margin software services with low-margin physical product sales.
The wide variance in gross margins implies that the company lacks a stable pricing power or a consistent cost-of-goods structure. This volatility makes it difficult to forecast future profitability, as the current margin profile appears highly sensitive to the specific product mix sold in any given quarter.
According to the provided financial filings, SCWorx has consistently failed to achieve positive operating income, with operating margins remaining deeply negative throughout the ten-quarter period, suggesting that the company has not yet realized the necessary scale to cover its fixed operating expenses.
The persistent gap between gross profit and operating income indicates that SG&A expenses remain disproportionately high relative to the company's current revenue base. Without a significant increase in recurring software revenue, the company appears unlikely to achieve the operating leverage required to reach break-even status.
As reported in the income statement data, the company's net income is frequently impacted by large, non-operating fluctuations, with net margins reaching as low as -186% in 2025Q3, which suggests that reported EPS figures may not accurately reflect the underlying operational performance of the business.
The significant disparity between operating losses and net losses warrants further investigation into non-operating items and potential impairments. Investors should be cautious of these bottom-line figures, as they appear to be heavily influenced by factors outside of the core healthcare information services operations.
Based on the provided financial figures, the company's reliance on disparate revenue streams and its inability to generate consistent positive cash flow suggest that the current business model may be fundamentally unsustainable without significant capital injections or a strategic pivot toward a more focused software-only approach.
Short-sellers would likely focus on the company's inability to scale its core data normalization platform while simultaneously managing unrelated business lines like ticketing. The lack of a clear path to profitability suggests that the company may face continued pressure on its valuation and liquidity.
Quick answers to the most common questions about buying WORX stock.
For fiscal year 2025, SCWorx Corp. (WORX) reported total revenue of $2.9M. This represents a 386.5% increase compared to $0.6M in 2016.
SCWorx Corp. (WORX) reported a net loss of $4.4M for the fiscal year ending 2025.
SCWorx Corp. (WORX) reported an operating income of $-1.0M, resulting in an operating profit margin of -33.3%. This margin reflects the operational efficiency of the business before interest and taxes.
SCWorx Corp. (WORX) generated $0.9M in gross profit for the year, representing a gross profit margin of 32.0%. This demonstrates the company's core pricing power and production efficiency.